Skanska signs additional contract with Orlando Health in Florida, USA, worth USD 166M, about SEK 1.7 billion
STOCKHOLM, April 9, 2024 /PRNewswire/ -- Skanska has signed an additional contract with Orlando Health to build the 580,000-square-feet acute care Lakeland Highlands hospital in Lakeland, Florida. The contract is worth USD 166M, about SEK 1.7 billion, which will be included in the US order bookings for the first quarter of 2024.
The seven-story, 302-patient bed tower will feature a modular central utility plant, medical and support services including imaging, lab, and pharmacy. The hospital will also include additional healthcare amenities.
The initial contract was announced in July 2023. Construction scheduled for completion in 2026.
For further information please contact: Ashley Jeffery, Communications Mgr, Skanska USA Building, tel +1 813 459 3682 Andreas Joons, Press Officer, Skanska AB, tel +46 (0)10 449 04 94 Direct line for media, tel +46 (0)10 448 88 99
This and previous releases can also be found at www.skanska.com
Aptose Biosciences Inc. , a clinical- stage precision oncology company developing highly differentiated oral targeted agents to treat hematologic malignancies, will report financial results for the first quarter ended March 31, 2024, on Tuesday, May...
Spear Education, a leading provider of advanced dental education, today announced the appointment of technology executive Jim Milton to its Board of Directors. Mr. Milton is a recognized leader in the education technology space. He was named Higher...
WELL Health Technologies Corp. ("WELL" or the "Company"), a digital healthcare company focused on positively impacting health outcomes by leveraging technology to empower healthcare practitioners and their patients globally, is pleased to announce...
Centerline Biomedical, Inc. ("Centerline") has been awarded a MedTech Outlook Award as a 2024 Top Surgical Devices Company. The company is recognized for "Revolutionizing Interventional Procedures with IOPS Technology". Receiving the award, Founder...
K-Bro Linen Inc. ("K-Bro" or the "Corporation") today announces its Q1 2024 financial and operating results.
Q1 2024 Financial and Operating Highlights
Consolidated revenue increased 13.3% compared to Q1 2023, with healthcare revenue having...
Cartesian Therapeutics, Inc. (the "Company"), a clinical-stage biotechnology company developing mRNA cell therapies for the treatment of autoimmune diseases, today announced the granting of inducement awards to four new employees. On May 1, 2024,...
